HIGHLIGHTS
- who: Bo Zhang from the Sichuan University, China have published the paper: Characteristics of the immune microenvironment and their clinical significance in non-small cell lung cancer patients with ALK-rearranged mutation, in the Journal: (JOURNAL)
- how: The authors used the chi-square test to compare differences between categorical variables. The statistical results showed that the proportions of CD3+ CD8+ and CD20+ TILs were significantly different between the KRAS+ and ALK+ and EGFR+ NSCLC groups and the proportion was higher in KRAS+ NSCLC patients (all p and amplt 0.05 Figures 2K M P). The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.